Level of evidence: Therapeutic Level II
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Critical-sized defect (CSD) is one of the most challenging cases for orthopaedic surgeons. We aim to explore the therapeutic potential of the combination of bone marrow-derived mesenchymal stem cells (BM-MSCs), hydroxyapatite (HA) granules, bone morphogenetic protein-2 (BMP-2), and internal fixation for treating CSDs.
This was a translational study performed during the period of January 2012 to 2016. Subjects were patients diagnosed with CSDs who had previously failed surgical attempts. They were treated with the combination of autologous BM-MSCs, HA granules, BMP-2, and mechanical stabilization. Post-operative pain level, functional outcome, defect volume, and radiological healing were evaluated after a minimum follow-up of 12 months.
A total of six subjects were recruited in this study. The pain was significantly reduced in all cases; with the decrease of mean preoperative visual analog scale (VAS) from 4 ± 2.2 to 0 after six month follow-up. Clinical functional outcome percentage increased significantly from 25 ± 13.7 to 70.79 ± 19.5. Radiological healing assessment using Tiedemann score also showed an increase from 0.16 ± 0.4 to 8 ± 3 at one year follow-up. No immunologic nor neoplastic side effects were found.
The combination of autologous BM-MSCs, HA granules, and BMP-2 is safe and remains to be a good option for the definitive treatment for CSD with previous failed surgical attempts. Further studies with a larger sample size are required to be done.
Schmidmaier G, Capanna R, Wildemann B et al (2009) Bone morphogenetic proteins in critical-size bone defects: what are the options? Injury 40:S39–S43. https://doi.org/10.1016/S0020-1383(09)70010-5 CrossRef
Li Y, Chen SK, Li L et al (2015) Bone defect animal models for testing efficacy of bone substitute biomaterials. J Orthop Transl 3:95–104
Mauffrey C, Barlow BT, Smith W (2015) Management of segmental bone defects. J Am Acad Orthop Surg 23:143–153
Reichert JC, Saifzadeh S, Wullschleger ME et al (2009) The challenge of establishing preclinical models for segmental bone defect research. Biomaterials 30:2149–2163. https://doi.org/10.1016/j.biomaterials.2008.12.050 CrossRefPubMed
Perka C, Schultz O, Spitzer RS et al (2000) Segmental bone repair by tissue-engineered periosteal cell transplants with bioresorbable fleece and fibrin scaffolds in rabbits. Biomaterials 21:1145–1153. https://doi.org/10.1016/S0142-9612(99)00280-X CrossRefPubMed
Komaki H, Tanaka T, Chazono M, Kikuchi T (2006) Repair of segmental bone defects in rabbit tibiae using a complex of beta-tricalcium phosphate, type I collagen, and fibroblast growth factor-2. Biomaterials 27:5118–5126. https://doi.org/10.1016/j.biomaterials.2006.05.031 CrossRefPubMed
Gao TJ, Lindholm TS, Kommonen B et al (1996) Enhanced healing of segmental tibial defects in sheep by a composite bone substitute composed of tricalcium phosphate cylinder, bone morphogenetic protein, and type IV collagen. J Biomed Mater Res 32:505–512. https://doi.org/10.1002/(SICI)1097-4636(199612)32:4<505::AID-JBM2>3.0.CO;2-V CrossRefPubMed
Bucholz RW, Carlton A, Holmes R (1989) Interporous hydroxyapatite as a bone graft substitute in tibial plateau fractures. Clin Orthop Relat Res 240:53–62
Blokhuis TJ, Wippermann BW, Den Boer FC et al (2000) Resorbable calcium phosphate particles as a carrier material for bone marrow in an ovine segmental defect. J Biomed Mater Res 51:369–375. https://doi.org/10.1002/1097-4636(20000905)51:3<369::AID-JBM10>3.0.CO;2-J CrossRefPubMed
Stevenson S (1998) Enhancement of fracture healing with autogenous and allogeneic bone grafts. Clin Orthop Relat Res:S239–S246. https://doi.org/10.1177/1071100716649925
Yaman F, Dundar S, Cakmak O et al (2017) Guided bone regeneration with polyethylene membrane, zoledronic acid and hydroxiapatide bone graft in peri-implant bone defect: an experimental study. Biomed Res 28:2684–2688
Govender S, Csimma C, Genant HK et al (2002) Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: a prospective, controlled, randomized study of four hundred and fifty patients. J Bone Joint Surg Am 84–A:2123–2134. https://doi.org/10.1097/00003086-199706000-00008 CrossRef
Betz OB, Betz VM, Schröder C et al (2013) Repair of large segmental bone defects: BMP-2 gene activated muscle grafts vs. autologous bone grafting. BMC Biotechnol 13. https://doi.org/10.1186/1472-6750-13-65
Giannoudis PV, Einhorn TA, Marsh D (2007) Fracture healing: the diamond concept. Injury 38. https://doi.org/10.1016/S0020-1383(08)70003-2
Qu H, Guo W, Yang R et al (2015) Reconstruction of segmental bone defect of long bones after tumor resection by devitalized tumor-bearing bone. World J Surg Oncol:13. https://doi.org/10.1186/s12957-015-0694-3
Wang Y, Jiang H, Deng Z et al (2017) Comparison of monolateral external fixation and internal fixation for skeletal stabilisation in the management of small tibial bone defects following successful treatment of chronic osteomyelitis. Biomed Res Int. https://doi.org/10.1155/2017/6250635
Lubis AMT, Sandhow L, Lubis VK et al (2011) Isolation and cultivation of mesenchymal stem cells from iliac crest bone marrow for further cartilage defect management. Acta Med Indones 43:178–184 PubMed
Binkley JM, Stratford PW, Lott SA, Riddle DL (1999) The lower extremity functional scale (LEFS): scale development, measurement properties, and clinical application. Phys Ther 79:371–383. https://doi.org/10.1097/00005650-198903001-00007 CrossRefPubMed
Hudak PL, Amadio PC, Bombardier C (1996) Development of an upper extremity outcome measure: the DASH (disabilities of the arm, shoulder, and hand). Am J Ind Med 29:602–608. https://doi.org/10.1002/(SICI)1097-0274(199606)29:6<602::AID-AJIM4>3.0.CO;2-L CrossRef
Tiedeman JJ, Lippiello L, Connolly JF, Strates BS (1990) Quantitative roentgenographic densitometry for assessing fracture healing. Acta Orthop Scand 61:128–130 CrossRef
Dilogo IH, Kholinne E, Djaja YP, Yuyus Kusnadi LS (2014) Osteogenic potency of human bone marrow mesenchymal stem cells from femoral atrophic non-union fracture site. J Clin Exp Investig 5:159–163. https://doi.org/10.5799/ahinjs.01.2014.02.0382 CrossRef
Wang X, Luo F, Huang K, Xie Z (2016) Induced membrane technique for the treatment of bone defects due to post-traumatic osteomyelitis. Bone Joint Res 5:101–105. https://doi.org/10.1302/2046-3758.53.2000487 CrossRefPubMedPubMedCentral
Bajada S, Harrison PE, Ashton BA et al (2007) Successful treatment of refractory tibial nonunion using calcium sulphate and bone marrow stromal cell implantation. J Bone Joint Surg (Br) 89:1382–1386. https://doi.org/10.1302/0301-620X.89B10.19103 CrossRef
Asadi-Eydivand M, Solati-Hashjin M, Shafiei SS et al (2016) Structure, properties, and in vitro behavior of heat-treated calcium sulfate scaffolds fabricated by 3D printing. PLoS One 11. https://doi.org/10.1371/journal.pone.0151216
Sánchez F, Bolarm A, Molera P (2003) Relationship between particle size and manufacturing processing and sintered characteristics of iron powders. Rev Latin Met Mat 23:35–40
Gao Y, Li C, Wang H, Fan G (2015) Acceleration of bone-defect repair by using A-W MGC loaded with BMP2 and triple point-mutant HIF1α-expressing BMSCs. J Orthop Surg Res 10. https://doi.org/10.1186/s13018-015-0219-3
Carragee EJ, Hurwitz EL, Weiner BK (2011) A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learned. Spine J 11:471–491. https://doi.org/10.1016/j.spinee.2011.04.023 CrossRef
Dilogo IH, Kamal AF, Gunawan B, Rawung RV (2015) Autologous mesenchymal stem cell (MSCs) transplantation for critical-sized bone defect following a wide excision of osteofibrous dysplasia. Int J Surg Case Rep 17:106–111. https://doi.org/10.1016/j.ijscr.2015.10.040 CrossRefPubMedPubMedCentral
- Autologous mesenchymal stem cell implantation, hydroxyapatite, bone morphogenetic protein-2, and internal fixation for treating critical-sized defects: a translational study
Ismail Hadisoebroto Dilogo
Yoshi Pratama Djaja
Nyimas Diana Yulisa
- Springer Berlin Heidelberg
Neu im Fachgebiet Orthopädie und Unfallchirurgie
Mail Icon II